Joanne Berger-Sweeney

Berger-Sweeney in 2012 Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Joanne E. Berger-Sweeney', query time: 0.02s Refine Results
  1. 1
    Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.

    Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome. by Laura R Schaevitz, Raffaella Nicolai, Carla M Lopez, Stefania D'Iddio, Emerenziana Iannoni, Joanne E Berger-Sweeney

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Preclinical research in Rett syndrome: setting the foundation for translational success

    Preclinical research in Rett syndrome: setting the foundation for translational success by David M. Katz, Joanne E. Berger-Sweeney, James H. Eubanks, Monica J. Justice, Jeffrey L. Neul, Lucas Pozzo-Miller, Mary E. Blue, Diana Christian, Jacqueline N. Crawley, Maurizio Giustetto, Jacky Guy, C. James Howell, Miriam Kron, Sacha B. Nelson, Rodney C. Samaco, Laura R. Schaevitz, Coryse St. Hillaire-Clarke, Juan L. Young, Huda Y. Zoghbi, Laura A. Mamounas

    Published 2012-11-01
    Get full text
    Article

Search Tools: